Fellows

Dr. Cheng earned her bachelor’s degree from the School of Nursing at Shanghai Jiao Tong University, and her master’s and doctoral degrees from the School of Nursing at Fudan University. Her doctoral dissertation focused on evidence implementation frameworks in nursing practice in China. From 2016 to 2017, she was a joint PhD student at Duke University, where she participated in research on implementation science and supportive care for pediatric cancer. From 2019 to 2020, she was a visiting scholar at the Department of Nursing Science, Professional Practice & Quality at the National Children’s Hospital, where she contributed to research on pediatric patient-reported outcomes and palliative care.Her current research focuses on improving the quality of care and overall well-being of children with serious illnesses and their families across the disease trajectory. Her work has been supported by competitive grants from the National Natural Science Foundation of China, the China Association for Science and Technology, the Shanghai Pujiang Program, and the China Medical Board. As a 2025 Fellow of the China Medical Board Global Health Leadership Development Program, she will undertake a one-year fellowship at Yale School of Medicine, including a nine-month field placement in Ghana. Under the mentorship of Drs. LaRon E. Nelson and Shelli L. Feder from Yale, and in collaboration with Dr. Eva Mensah, Director of Nursing Services, Ghana Health Service, and Mrs. Theresa Abena Jamebe Antwi, Principal, Public Health Nurses’School, her project focuses on “Empowering Community Health Nurses for Pediatric Palliative Care in Ghana”.

Xiaoting Yang is a postgraduate fellow in Yale-China Medical Board Global Health Leadership Development Program. She is an Investment Manager at Haier Biomedical, a leading service provider of digital solutions for life sciences and medical innovation through IoT transformation. In her previous role as Strategic Director of Haier Hematologi, she played a pivotal role in the strategic planning and merger integration of various new industries, including blood component separation and application, biological reagents, and scientific analytical instruments for Haier Biomedical. She holds a master’s degree in Bioengineering from Ocean University of China and also has hands-on experience in research and development for in vitro diagnostics (IVD). She is joining Professor Albert Ko's team to work on wastewater surveillance for infectious diseases at Yale and Fiocruz Bahia in 2025.

Site: Brazil

Project Title: Molecular Genetic Testing for Monitoring Pathogens in Wastewater Surveillance in Salvador, Brazil

Sheng Bi is currently an attending physician at the Infectious Diseases Department of the First Affiliated Hospital of Zhejiang University, which is one center of the National Medical Centers for Infectious Diseases. In the year of 2015, he received his doctoral degree from Zhejiang University in Internal Medicine. His research interests are in the epidemiology of tuberculosis and nontuberculous mycobacterium, as well as the antimicrobial resistance and mechanisms. Dr. Bi has worked on a number of research studies, including one key national research project sponsored by ministry of Science and Technology. He holds committee membership in several academic associations.

Site: Brazil

Project Title: A study of SARS-CoV-2 infections in Pau da Lima slum community

Xiao Lin is the founder of WECAN, a social enterprise that aims to improve well-being in China. She is also a health marketing specialist with solid experience in the industry. She started her career at Procter & Gamble, where she learned the fundamentals of marketing. Later, she joined Chunyu, one of the top mobile health startups in China, as a business unit leader. There, she successfully created a new business model for public education live streaming, featuring renowned surgeons who explained medical terms in plain language with public insights. As a trained psychologist, Ms. Lin has been promoting well-being in China since 2017. She has served more than 30,000 consumers and received 24 million views. She knows how to bridge the gap between public needs and scientific research. She plans to use her marketing insights and project management skills to promote public well-being in global health. Ms. Lin received her bachelor's degree in psychology from Beijing Normal University (2002-2006) and master’s degree in marketing from Peking University (2006-2009).

Site: Peru

Project Title: Development and Implementation of a Health Beliefs Model-Based Intervention to Promote Osteoporosis-Related Knowledge, Self-Efficacy and Health Beliefs among Andean Women in Peru

Mr. Yang Lu is currently a business manager at the International Business Division of China Sinopharm International Corporation. As the head of the Government Affairs Department in Sinopharm Biotech, Yang has developed and implemented several biomedical projects during last ten years in low- and middle-income countries, including as Kenya, Ecuador, Sri Lanka and Pakistan. He served as a project coordinator for the international multi-center clinical trial of the COVID-19 biotech product and real-world study from 2020 to 2021. He has been recognized for his special contributions to government-to-government projects and development of international cooperation in public health.

Mr. Lu received his bachelor’s degree from the Beijing Forestry University in 2007 and has completed the Modern Logistic Management On-the-Job Postgraduate Program at the University of International Business and Economy (2012), and the Medical Device Quality Management System Training Program (2023). His practice focuses on the development of the primary healthcare facilities and improving the public health system.

Site: Nigeria

Project Title: Strengthening the oxygen delivery system across Nigeria

Dr. Yujia Qiu is an attending psychiatrist and a researcher at Peking University Sixth Hospital, NHC Key Laboratory of Mental Health (Peking University), and National Clinical Research Center for Mental Disorders. She received her MD and MS from Peking University respectively in 2022 and 2011 in psychiatry and mental health. She has been qualified as a Certified Alcohol and Drugs Counselor by the Hong Kong Association of Professionals Specializing in Addiction Counseling and International Certification & Reciprocity Consortium (2014-2018). She has received many clinical and teaching awards. Dr. Qiu’s primary research focuses on addiction medicine. She has received national research grants and published several first-author manuscripts in the field. She also holds committee membership in several academic associations.

Site: Malaysia

Project Title: Adverse childhood experiences, stigma, and their association with utilization of HIV services among people with HIV who inject drugs

Dr. Jingfeng Ding is a registered nurse in China and completed his PhD in population health at the University of Western Australia (UWA) in December 2020. He is now working as a lecturer and research fellow at Xiangya School of Nursing, Central South University. He is also a joint research fellow at UWA and an Associate Supervisor of PhD students at University of Wollongong, Australia. His research interests are in palliative care and health services. Dr. Ding has extensive experience in both quantitative and qualitative research. He has published more than 20 peer-reviewed papers in high-impact journals and presented his research at several international academic conferences. Dr Ding is a member of the Palliative Care Committee of the China Anti-cancer Association (CACA) and Nursing Committee of the China Medical Education Association (CMEA).

Dan Li is currently a Research Associate at the Public Health Emergency Center of the Chinese Center for Disease Control and Prevention (China CDC). She completed the Public Health Emergency Management Capacity Building Program at the US CDC in 2014 and the Chinese Field Epidemiology Training Program from 2015-2017.

Li is a PhD candidate at the Chinese Center for Tropical Diseases Research and is majoring in epidemiology and health statistics. Her research focuses on the prevention and control of emerging infectious diseases. She served as project manager for the National Health Commission in 2011. Since then, she has worked on a number of research studies, including two key national research projects sponsored by Ministry of Science and Technology.

Dr. Jiang Long is a psychiatrist researcher at Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine. He received his PhD from Central South University in 2018 with joint training at the Université Catholique de Louvain in Belgium, in psychiatry and mental health. He served as a full-time consultant at the WHO (2019-2020) and a seconded officer at the National Health Commission of China (2020-2021). His research focuses on addiction medicine and public mental health. He has authored over 30 peer-reviewed journal articles and editorials and co-edited a national textbook in psychology. He holds committee membership in several academic associations.

Dr. Meng Xiao is a clinical microbiologist and Assistant Director of Department of Laboratory Medicine, Peking Union Medical College Hospital in China. His research focuses on epidemiology of fungal pathogen and their phylogeny and antimicrobial resistant mechanisms, as well as the implementation of novel laboratory tools for diagnosis of infectious diseases. He has received national and provincial research funding, and has over 50 publications as first, co-first or corresponding author. He also serves as the Secretary General for the Expert Committee of China Fungal Disease Surveillance System, National Health Commission of China.